Meridiem Capital Partners LP Care Dx, Inc. Call Options Transaction History
Meridiem Capital Partners LP
- $1.42 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDNA
# of Institutions
209Shares Held
56MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$78.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$72.5 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$37.6 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$36 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$32.2 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $790M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...